Entourage Health Corp Stock Target Price
ENTG Stock | 0.01 0.01 100.00% |
Entourage Health Corp fundamentals help investors to digest information that contributes to Entourage Health's financial success or failures. It also enables traders to predict the movement of Entourage Stock. The fundamental analysis module provides a way to measure Entourage Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Entourage Health stock.
Entourage | Target Price |
Entourage Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Entourage Health from analyzing Entourage Health's financial statements. These drivers represent accounts that assess Entourage Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Entourage Health's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 99.8M | 51.0M | 19.9M | 6.1M | 4.6M | 4.4M | |
Enterprise Value | 139.5M | 109.5M | 103.9M | 131.6M | 155.0M | 162.8M |
Entourage Fundamentals
Return On Equity | -3.71 | ||||
Return On Asset | -0.37 | ||||
Profit Margin | (1.07) % | ||||
Operating Margin | (0.38) % | ||||
Current Valuation | 173.72 M | ||||
Shares Outstanding | 308.39 M | ||||
Shares Owned By Insiders | 20.17 % | ||||
Number Of Shares Shorted | 7 | ||||
Price To Book | 2.69 X | ||||
Price To Sales | 0.04 X | ||||
Revenue | 40.71 M | ||||
Gross Profit | (11.71 M) | ||||
EBITDA | (17.46 M) | ||||
Net Income | (46.17 M) | ||||
Total Debt | 155.11 M | ||||
Book Value Per Share | (0.53) X | ||||
Cash Flow From Operations | (10.24 M) | ||||
Earnings Per Share | (0.14) X | ||||
Target Price | 0.05 | ||||
Beta | 1.06 | ||||
Market Capitalization | 1.54 M | ||||
Total Asset | 31.39 M | ||||
Retained Earnings | (365.54 M) | ||||
Working Capital | (146.91 M) | ||||
Net Asset | 31.39 M |
About Entourage Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Entourage Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Entourage Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Entourage Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Entourage Stock Analysis
When running Entourage Health's price analysis, check to measure Entourage Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entourage Health is operating at the current time. Most of Entourage Health's value examination focuses on studying past and present price action to predict the probability of Entourage Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entourage Health's price. Additionally, you may evaluate how the addition of Entourage Health to your portfolios can decrease your overall portfolio volatility.